List of SBIR/STTR awards granted to Auritec Pharmaceuticals, Inc
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Auritec Pharmaceuticals, Inc in April, 2019 for $860,561.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI136201-02A1 | Phase II | 860,561 | April 4, 2019 | |||||||
A SBIR Phase II contract was awarded to Auritec Pharmaceuticals, Inc in July, 2019 for $999,998.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI124815-02A1 | Phase II | 999,998 | July 22, 2019 | |||||||
A SBIR Phase I contract was awarded to Auritec Pharmaceuticals, Inc in September, 2020 for $253,692.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44DA053073-01 | Phase I | 253,692 | September 30, 2020 | |||||||
A SBIR Phase II contract was awarded to Auritec Pharmaceuticals, Inc in September, 2021 for $845,335.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44DA053073-02 | Phase II | 845,335 | September 1, 2021 | |||||||
A SBIR Phase II contract was awarded to Auritec Pharmaceuticals, Inc in July, 2022 for $1,024,014.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI170362-01A1 | Phase II | 1,024,014 | July 8, 2022 | |||||||
A SBIR Phase I contract was awarded to Auritec Pharmaceuticals, Inc in February, 2018 for $224,484.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI136201-01 | Phase I | 224,484 | February 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Auritec Pharmaceuticals, Inc in July, 2016 for $219,324.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI124815-01 | Phase I | 219,324 | July 8, 2016 | |||||||
A SBIR Phase II contract was awarded to Auritec Pharmaceuticals, Inc in September, 2015 for $1,482,501.0 USD from the U.S. Department of Health & Human Services. | SBIR | 9R44MH110161-05 | Phase II | 1,482,501 | September 24, 2015 | |||||||
A SBIR Phase I contract was awarded to Auritec Pharmaceuticals, Inc in September, 2017 for $224,881.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HD090870-01A1 | Phase I | 224,881 | September 1, 2017 | |||||||
A SBIR Phase II contract was awarded to Auritec Pharmaceuticals, Inc in April, 2015 for $1,301,280.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HD075636-02 | Phase II | 1,301,280 | April 1, 2015 | |||||||
A SBIR Phase II contract was awarded to Auritec Pharmaceuticals, Inc in August, 2016 for $1,299,084.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2U44AI069674-04A1 | Phase II | 1,299,084 | August 15, 2016 | |||||||
A SBIR Phase II contract was awarded to Auritec Pharmaceuticals, Inc for $1,191,901.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AR053025-02A1 | Phase II | 1,191,901 | ||||||||
A STTR Phase I contract was awarded to Auritec Pharmaceuticals, Inc for $211,862.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI104549-01 | Phase I | 211,862 | ||||||||
A SBIR Phase II contract was awarded to Auritec Pharmaceuticals, Inc for $1,073,890.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44MH068925-02A2 | Phase II | 1,073,890 | ||||||||
A SBIR Phase I contract was awarded to Auritec Pharmaceuticals, Inc for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AR053025-01 | Phase I | 100,000 | ||||||||
A SBIR Phase II contract was awarded to Auritec Pharmaceuticals, Inc for $775,307.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HD050146-02A1 | Phase II | 775,307 | ||||||||
A SBIR Phase I contract was awarded to Auritec Pharmaceuticals, Inc for $223,952.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI081552-01 | Phase I | 223,952 | ||||||||
A SBIR Phase II contract was awarded to Auritec Pharmaceuticals, Inc for $326,938.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44NS049918-02A1 | Phase II | 326,938 | ||||||||
A SBIR Phase II contract was awarded to Auritec Pharmaceuticals, Inc for $1,330,820.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI069674-02 | Phase II | 1,330,820 | ||||||||
A SBIR Phase I contract was awarded to Auritec Pharmaceuticals, Inc for $300,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI098473-01A1 | Phase I | 300,000 | ||||||||
A SBIR Phase I contract was awarded to Auritec Pharmaceuticals, Inc for $338,981.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HD075636-01 | Phase I | 338,981 | ||||||||
A SBIR Phase I contract was awarded to Auritec Pharmaceuticals, Inc for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43MH068925-01A1 | Phase I | 100,000 | ||||||||
A SBIR Phase I contract was awarded to Auritec Pharmaceuticals, Inc for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS049918-01A1 | Phase I | 100,000 | ||||||||
A SBIR Phase I contract was awarded to Auritec Pharmaceuticals, Inc for $99,120.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI069674-01A1 | Phase I | 99,120 | ||||||||
A SBIR Phase I contract was awarded to Auritec Pharmaceuticals, Inc for $296,405.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43EY021663-01A1 | Phase I | 296,405 |
